Ai
Aimmune (Nestle)
Brisbane CAFounded 2011300 employees
Private CapbiotechAcquiredImmunology
Platform: Palforzia Peanut
Market Cap
N/A
All Drugs
2
Clinical Trials
4
Failed / Terminated
0
FDA Approved
1
Drug Pipeline (2 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| Capibrutinib | AIM-1053 | Approved | 2 | TROP-2 | ObesityPAH | ||
| Pexafotisoran | AIM-5409 | Phase 1/2 | 2 | GIP-R | Parkinson's |
Financial Documents
This company has been acquired — see parent company for financial filings.
Catalyst Events (4)